Neos Therapeutics, Inc. (NEOS): Price and Financial Metrics

Neos Therapeutics, Inc. (NEOS)

Today's Latest Price: $1.56 USD

0.01 (0.65%)

Updated Feb 14 12:00am

Add NEOS to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 215 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

NEOS Stock Summary

  • The capital turnover (annual revenue relative to shareholder's equity) for NEOS is -20.88 -- better than just 0.81% of US stocks.
  • NEOS's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of 99.7% of US stocks.
  • Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for NEOS comes in at -35.53% -- higher than that of merely 9.15% of stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Neos Therapeutics Inc are STIM, ISR, HBIO, EML, and KEM.
  • NEOS's SEC filings can be seen here. And to visit Neos Therapeutics Inc's official web site, go to
NEOS Daily Price Range
NEOS 52-Week Price Range

NEOS Stock Price Chart More Charts

NEOS Price/Volume Stats

Current price $1.56 52-week high $3.62
Prev. close $1.55 52-week low $1.13
Day low $1.51 Volume 135,300
Day high $1.60 Avg. volume 256,761
50-day MA $1.54 Dividend yield N/A
200-day MA $1.57 Market Cap 77.58M

Neos Therapeutics, Inc. (NEOS) Company Bio

Neos Therapeutics develops, manufactures, and commercializes products for the treatment of attention deficit hyperactivity disorder (ADHD) using its drug delivery technologies. The company was founded in 2008 and is based in Grand Prairie, Texas.

NEOS Latest News Stream

Event/TimeNews Detail
Loading, please wait...

NEOS Latest Social Stream

Loading social stream, please wait...

View Full NEOS Social Stream

NEOS Price Returns

1-mo -2.50%
3-mo 1.30%
6-mo -15.90%
1-year -35.00%
3-year -72.39%
5-year N/A
YTD 3.31%
2019 -8.48%
2018 -83.82%
2017 74.36%
2016 -59.15%
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.5888 seconds.